Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2003
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332130A2 Atorvastatin hemi-calcium form vii
08/06/2003EP1332128A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1331972A2 Pharmaceutical compositions
08/06/2003EP1331950A1 Methods and compositions for nucleic acid delivery
08/06/2003EP1331947A2 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent
08/06/2003EP1331946A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331937A2 Dibenzoxazepine alpha v integrin receptor antagonist
08/06/2003EP1331933A2 The use of tiagabine for treatment of diabetic neuropathy and migraine
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1331925A2 Use of an association of at least a carotenoid and of at least an isoflavonoid for treating cutaneous symptoms of ageing
08/06/2003EP1331924A2 Use of carotenoids for treating ageing symptoms
08/06/2003EP1331923A2 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid
08/06/2003EP1244498B1 Combination of trimebutine with an opioid analgesic
08/06/2003EP1189929B1 Factor viia inhibitors
08/06/2003EP1173187B1 Combined preparations comprising morpholine anthracyclines and platinum derivatives
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1126846B1 Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1109811B1 Pyrrolobenzodiazepines
08/06/2003EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage
08/06/2003EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP0983064B1 PYRROLES AS sPLA2 INHIBITORS
08/06/2003EP0980381B1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders
08/06/2003EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/06/2003EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
08/06/2003EP0824350B1 Use of an antifungal composition
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0806949B1 New pharmaceutical composition containing trimebutine and preparation process
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003EP0695305B1 Method of forming oligonucleotides
08/06/2003CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434828A Novel bisamidate phosphonate prodrugs
08/06/2003CN1434825A Novel imidazo ÒÇö1,3,5ÒÇòtriazinones and the use thereof
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434724A Remedies and/or preventives for nervous system disorders
08/06/2003CN1434719A Preparation capable of mobilization of activity
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434707A Method and compositions for preventing hormone induced adverse effects
08/06/2003CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy
08/06/2003CN1433800A Method for producing health care capsule for beautifying and delaying senility
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117089C Substituted 2(2,6-dioxopiperidin-3-yl)phthaliomides and -1-xoisoindolines and method of reducing TNF-alpha levels
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/06/2003CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
08/06/2003CN1116897C Parathyroid hormone medicine coposition
08/06/2003CN1116879C Process for preparing compound pancreatic ribonucleate for injection
08/05/2003US6603998 Delivery of macromolecules into cells
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6603002 Process and intermediates for growth hormone secretagogues
08/05/2003US6602987 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules
08/05/2003US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
08/05/2003US6602910 Treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602891 Muscarinic receptor agonists
08/05/2003US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
08/05/2003US6602889 5-heteroaryl substituted indoles
08/05/2003US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia
08/05/2003US6602883 Inhibitors of farnesyl protein transferase
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602876 Adhesion receptor antagonists
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602664 3′-azido-2′,3′-dideoxyuridine in an anti-HIV effectiveness test protocol
08/05/2003US6601580 Enhancing therapeutic effectiveness of nitric oxide inhalation
08/05/2003CA2419989A1 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 1564